Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
for
Wilms Tumor, Rhabdoid Tumor,
Location: Washington D.C. DC, Basking Ridge NJ, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 1+
Code: NCT05985161
Phase 2, Recruiting
ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study
for
Suspected CSF Shunt Obstruction
Location: Washington DC, Baltimore MD, Wilmington DE,
Location: Washington DC, New York NY, Indianapolis IN, Chicago IL,
Sponsor: Recordati Rare Diseases
Sex: All
Age: 0+
Code: NCT05040178
Recruiting
The Pediatric Anesthesia Quality Improvement Project
for
Surgery, Anesthesia, Children
Location: Washington DC, Baltimore MD, Hershey PA, Wilmington DE,
Sponsor: The Society for Pediatric Anesthesia
Sex: All
Age: 0 - 21
Code: NCT00674388
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Washington D.C. DC, Bethesda MD, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase 3, Recruiting
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
for
Sexually Transmitted Diseases
Location: Washington D.C. DC
Sponsor: Children's National Research Institute
Sex: All
Age: 15 - 21
Code: NCT04372485
Recruiting
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Washington D.C. DC, Philadelphia PA, Pittsburgh PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase 2, Phase 3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Washington D.C. DC, Bethesda MD, Falls Church VA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
for
Low-grade Glioma, Advanced Solid Tumor
Location: Washington DC, Philadelphia PA, New York NY, Durham NC,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 0 - 25
Code: NCT04775485
Phase 2, Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Washington D.C. DC, Bethesda MD, Hershey PA,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase 2, Recruiting
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
for
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS,
Location: Washington D.C. DC, Baltimore MD
Sponsor: Catherine Bollard
Sex: All
Age: 0 - 70+
Code: NCT02203903
Phase 1, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: Washington D.C. DC, Baltimore MD, Richmond VA,